W. David Dotson

2.5k total citations · 1 hit paper
34 papers, 1.7k citations indexed

About

W. David Dotson is a scholar working on Genetics, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, W. David Dotson has authored 34 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 12 papers in Molecular Biology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in W. David Dotson's work include BRCA gene mutations in cancer (20 papers), Genomics and Rare Diseases (9 papers) and Ethics in Clinical Research (6 papers). W. David Dotson is often cited by papers focused on BRCA gene mutations in cancer (20 papers), Genomics and Rare Diseases (9 papers) and Ethics in Clinical Research (6 papers). W. David Dotson collaborates with scholars based in United States, Netherlands and Canada. W. David Dotson's co-authors include Muin J. Khoury, Linda Bradley, Michael P. Douglas, Katherine Kolor, Glenn E. Palomaki, James E. Haddow, Steven M. Teutsch, Ned Calonge, Alfred O. Berg and Margaret Piper and has published in prestigious journals such as American Journal of Public Health, Journal of Bacteriology and Clinical Pharmacology & Therapeutics.

In The Last Decade

W. David Dotson

32 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group

2009 484 citations Linda Bradley, Glenn E. Palomaki et al. Genetics in Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. David Dotson United States	23	794	362	339	306	283	34	1.7k
Ron Zimmern United Kingdom	17	1.1k 1.4×	298 0.8×	435 1.3×	211 0.7×	273 1.0×	35	1.6k
Adam H. Buchanan United States	24	1.2k 1.5×	387 1.1×	301 0.9×	500 1.6×	348 1.2×	77	2.0k
Sylvie Provost Canada	26	368 0.5×	254 0.7×	803 2.4×	141 0.5×	243 0.9×	80	2.4k
Julianne O’Daniel United States	21	1.9k 2.4×	550 1.5×	489 1.4×	97 0.3×	687 2.4×	53	2.7k
Tara M. Friebel United States	12	1.9k 2.3×	688 1.9×	383 1.1×	589 1.9×	245 0.9×	21	2.3k
Julie A. Lynch United States	20	297 0.4×	207 0.6×	174 0.5×	269 0.9×	111 0.4×	108	1.1k
Katherine Kolor United States	16	508 0.6×	132 0.4×	215 0.6×	148 0.5×	207 0.7×	28	957
Chiledum Ahaghotu United States	21	314 0.4×	151 0.4×	330 1.0×	265 0.9×	217 0.8×	39	1.2k
Shelly Cummings United States	20	1.1k 1.4×	374 1.0×	370 1.1×	431 1.4×	197 0.7×	42	1.6k
Mary Ann Gilligan United States	13	1.0k 1.3×	530 1.5×	164 0.5×	996 3.3×	186 0.7×	15	2.1k

Countries citing papers authored by W. David Dotson

Since Specialization

Citations

This map shows the geographic impact of W. David Dotson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. David Dotson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. David Dotson more than expected).

Fields of papers citing papers by W. David Dotson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. David Dotson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. David Dotson. The network helps show where W. David Dotson may publish in the future.

Co-authorship network of co-authors of W. David Dotson

This figure shows the co-authorship network connecting the top 25 collaborators of W. David Dotson. A scholar is included among the top collaborators of W. David Dotson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. David Dotson. W. David Dotson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Green, Ridgely Fisk, Ramal Moonesinghe, Sun Hee Rim, et al.. (2025). A comparison of family health history of breast cancer, colorectal cancer, and diabetes in self-reported survey and electronic health records data, All of Us Research Program. Genetics in Medicine Open. 3. 103439–103439.

Moonesinghe, Ramal, Lu Shi, Gail P. Jarvik, et al.. (2025). Association of HFE genotypes with hemochromatosis-related phenotypes in the All of Us research program. Genetics in Medicine Open. 3. 101959–101959.

Khoury, Muin J., Scott Bowen, W. David Dotson, et al.. (2022). Health equity in the implementation of genomics and precision medicine: A public health imperative. Genetics in Medicine. 24(8). 1630–1639. 89 indexed citations

Green, Ridgely Fisk, et al.. (2022). COVID-19-related health outcomes in people with primary immunodeficiency: A systematic review. Clinical Immunology. 243. 109097–109097. 24 indexed citations

Allen, Caitlin G., Ridgely Fisk Green, Scott Bowen, et al.. (2021). Challenges and Opportunities for Communication about the Role of Genomics in Public Health. Public Health Genomics. 24(1-2). 67–74. 3 indexed citations

Dotson, W. David, et al.. (2020). Barriers and facilitators for cascade testing in genetic conditions: a systematic review. European Journal of Human Genetics. 28(12). 1631–1644. 98 indexed citations

Green, Ridgely Fisk, Mary D. Ari, Katherine Kolor, et al.. (2018). Evaluating the role of public health in implementation of genomics-related recommendations: a case study of hereditary cancers using the CDC Science Impact Framework. Genetics in Medicine. 21(1). 28–37. 30 indexed citations

Chen, Zhuo, Katherine Kolor, Scott D. Grosse, et al.. (2017). Trends in utilization and costs of BRCA testing among women aged 18–64 years in the United States, 2003–2014. Genetics in Medicine. 20(4). 428–434. 48 indexed citations

Khoury, Muin J., Michael Bowen, Mindy Clyne, et al.. (2017). From public health genomics to precision public health: a 20-year journey. Genetics in Medicine. 20(6). 574–582. 98 indexed citations

10.

Lynch, Julie A., Brygida Berse, W. David Dotson, et al.. (2017). Utilization of genetic tests: analysis of gene-specific billing in Medicare claims data. Genetics in Medicine. 19(8). 890–899. 31 indexed citations

11.

Yu, Wei, Marta Gwinn, W. David Dotson, et al.. (2016). A knowledge base for tracking the impact of genomics on population health. Genetics in Medicine. 18(12). 1312–1314. 16 indexed citations

12.

Clyne, Mindy, Sheri D. Schully, W. David Dotson, et al.. (2014). Horizon scanning for translational genomic research beyond bench to bedside. Genetics in Medicine. 16(7). 535–538. 22 indexed citations

13.

Dotson, W. David, et al.. (2014). Clinical utility of gene-expression profiling in women with early breast cancer: an overview of systematic reviews. Genetics in Medicine. 17(7). 519–532. 23 indexed citations

14.

Dotson, W. David, Michael P. Douglas, Katherine Kolor, et al.. (2013). Prioritizing Genomic Applications for Action by Level of Evidence: A Horizon-Scanning Method. Clinical Pharmacology & Therapeutics. 95(4). 394–402. 46 indexed citations

15.

Khoury, Muin J., Marta Gwinn, W. David Dotson, & Sheri D. Schully. (2012). Knowledge integration at the center of genomic medicine. Genetics in Medicine. 14(7). 643–647. 22 indexed citations

16.

Bowen, Michael, Katherine Kolor, W. David Dotson, Renée M. Ned, & Muin J. Khoury. (2012). Public Health Action in Genomics Is Now Needed beyond Newborn Screening. Public Health Genomics. 15(6). 327–334. 41 indexed citations

17.

Khoury, Muin J., Marta Gwinn, W. David Dotson, & Michael Bowen. (2011). Is there a need for PGxceptionalism?. Genetics in Medicine. 13(10). 866–867. 7 indexed citations

18.

Gwinn, Marta, Daurice A. Grossniklaus, Wei Yu, et al.. (2011). Horizon scanning for new genomic tests. Genetics in Medicine. 13(2). 161–165. 32 indexed citations

19.

Bellcross, Cecelia & W. David Dotson. (2010). Tumor Gene Expression Profiling in Women with Breast CancerTest Category: Prognostic. PLoS Currents. 2. RRN1178–RRN1178. 2 indexed citations

20.

Palomaki, Glenn E., Linda Bradley, Michael P. Douglas, Katherine Kolor, & W. David Dotson. (2009). Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review. Genetics in Medicine. 11(1). 21–34. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact